Ikarian Capital, LLC Eledon Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,025,221 shares of ELDN stock, worth $3.13 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
1,025,221
Previous 1,126,637
9.0%
Holding current value
$3.13 Million
Previous $4.61 Million
24.57%
% of portfolio
0.49%
Previous 0.76%
Shares
7 transactions
Others Institutions Holding ELDN
# of Institutions
87Shares Held
37.3MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$19.2 Million0.94% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$10.9 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$9.01 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$7.1 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$7.04 Million2.06% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $42M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...